b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" Owner="NLM">\n        <PMID Version="1">30301828</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>27</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>02</Month>\n            <Day>27</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Print">1078-0432</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>25</Volume>\n                    <Issue>2</Issue>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>01</Month>\n                        <Day>15</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Clinical cancer research : an official journal of the American Association for Cancer Research</Title>\n                <ISOAbbreviation>Clin. Cancer Res.</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Telomerase Activation and ATRX Mutations Are Independent Risk Factors for Metastatic Pheochromocytoma and Paraganglioma.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>760-770</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1158/1078-0432.CCR-18-0139</ELocationID>\n            <Abstract>\n                <AbstractText Label="PURPOSE">Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors. Whereas most PPGLs are benign, up to 20% may become metastatic with <i>SDHB</i>- and <i>FH</i>-mutated tumors showing the higher risk. We aimed at determining the contribution of immortalization mechanisms to metastatic progression.<b>Experimental Design:</b> Immortalization mechanisms were investigated in 200 tumors. To identify telomerase (+) tumors, we analyzed genomic alterations leading to transcriptional activation of <i>TERT</i> comprising promoter mutations, hypermethylation and gain copy number. To identify tumors that activated the alternative lengthening of telomere (ALT) mechanism, we combined analyses of telomere length by slot blot, telomere heterogeneity by telomere FISH, and <i>ATRX</i> mutations by next-generation sequencing. Univariate/multivariate and metastasis-free survival (MFS) and overall survival (OS) analyses were carried out for assessment of risk factors and clinical outcomes.</AbstractText>\n                <AbstractText Label="RESULTS">Only 37 of 200 (18.5%) tumors achieved immortalization. Telomerase activation occurred in 12 metastatic tumors and was prevalent in <i>SDHB</i>-mutated paragangliomas (<i>P</i> = 2.42e-09). ALT features were present in 25 tumors, mostly pheochromocytomas, regardless of metastatic status or molecular group (<i>P</i> = 0.169), yet <i>ATRX</i> mutations were found preferentially in <i>SDHB/FH</i>-mutated metastatic tumors (<i>P</i> = 0.0014). Telomerase activation and <i>ATRX</i> mutations were independent factors of poor prognosis: MFS (hazard ratio, 48.2 and 33.1; <i>P</i> = 6.50E-07 and 1.90E-07, respectively); OS (hazard ratio, 97.4 and 44.1; <i>P</i> = 4.30E-03 and 2.00E-03, respectively) and were associated with worse MFS and OS (log-rank tests <i>P</i> &lt; 0.0001).</AbstractText>\n                <AbstractText Label="CONCLUSIONS">Assessment of telomerase activation and <i>ATRX</i> mutations could be used to identify metastatic PPGLs, particularly in tumors at high risk of progression.</AbstractText>\n                <CopyrightInformation>\xc2\xa92018 American Association for Cancer Research.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y" EqualContrib="Y">\n                    <LastName>Job</LastName>\n                    <ForeName>Sylvie</ForeName>\n                    <Initials>S</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Programme Cartes d\'Identit\xc3\xa9 des Tumeurs, Ligue Nationale Contre Le Cancer, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y" EqualContrib="Y">\n                    <LastName>Draskovic</LastName>\n                    <ForeName>Irena</ForeName>\n                    <Initials>I</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>CNRS, UMR3244, Institut Curie, PSL Research University, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Sorbonne Universit\xc3\xa9s, UPMC, Univ Paris 06, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y" EqualContrib="Y">\n                    <LastName>Burnichon</LastName>\n                    <ForeName>Nelly</ForeName>\n                    <Initials>N</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>INSERM, UMR970, Paris-Cardiovascular Research Center, Equipe Labellis\xc3\xa9e par la Ligue contre le Cancer, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Universit\xc3\xa9 Paris Descartes, Sorbonne Paris Cit\xc3\xa9, Facult\xc3\xa9 de M\xc3\xa9decine, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Assistance Publique-H\xc3\xb4pitaux de Paris, H\xc3\xb4pital Europ\xc3\xa9en Georges Pompidou, Department of Genetics, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Buffet</LastName>\n                    <ForeName>Alexandre</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>INSERM, UMR970, Paris-Cardiovascular Research Center, Equipe Labellis\xc3\xa9e par la Ligue contre le Cancer, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Universit\xc3\xa9 Paris Descartes, Sorbonne Paris Cit\xc3\xa9, Facult\xc3\xa9 de M\xc3\xa9decine, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Cros</LastName>\n                    <ForeName>J\xc3\xa9r\xc3\xb4me</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>INSERM, UMR1149, H\xc3\xb4pital Beaujon, Department of Pathology, Clichy, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>L\xc3\xa9pine</LastName>\n                    <ForeName>Charles</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Universit\xc3\xa9 Paris Descartes, Sorbonne Paris Cit\xc3\xa9, Facult\xc3\xa9 de M\xc3\xa9decine, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Assistance Publique-H\xc3\xb4pitaux de Paris, H\xc3\xb4pital Europ\xc3\xa9en Georges Pompidou, Department of Genetics, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Venisse</LastName>\n                    <ForeName>Annabelle</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Assistance Publique-H\xc3\xb4pitaux de Paris, H\xc3\xb4pital Europ\xc3\xa9en Georges Pompidou, Department of Genetics, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Robidel</LastName>\n                    <ForeName>Estelle</ForeName>\n                    <Initials>E</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>INSERM, UMR970, Paris-Cardiovascular Research Center, Equipe Labellis\xc3\xa9e par la Ligue contre le Cancer, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Universit\xc3\xa9 Paris Descartes, Sorbonne Paris Cit\xc3\xa9, Facult\xc3\xa9 de M\xc3\xa9decine, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Verkarre</LastName>\n                    <ForeName>Virginie</ForeName>\n                    <Initials>V</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Assistance Publique-H\xc3\xb4pitaux de Paris, H\xc3\xb4pital Europ\xc3\xa9en Georges Pompidou, Department of Pathology, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Meatchi</LastName>\n                    <ForeName>Tchao</ForeName>\n                    <Initials>T</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Assistance Publique-H\xc3\xb4pitaux de Paris, H\xc3\xb4pital Europ\xc3\xa9en Georges Pompidou, Department of Pathology, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Sibony</LastName>\n                    <ForeName>Mathilde</ForeName>\n                    <Initials>M</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>INSERM, U1016, Institut Cochin, Paris, France. 10 CNRS UMR8104, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Assistance Publique H\xc3\xb4pitaux de Paris, H\xc3\xb4pital Cochin, Department of Pathology, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Amar</LastName>\n                    <ForeName>Laurence</ForeName>\n                    <Initials>L</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>INSERM, UMR970, Paris-Cardiovascular Research Center, Equipe Labellis\xc3\xa9e par la Ligue contre le Cancer, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Universit\xc3\xa9 Paris Descartes, Sorbonne Paris Cit\xc3\xa9, Facult\xc3\xa9 de M\xc3\xa9decine, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Assistance Publique-H\xc3\xb4pitaux de Paris, H\xc3\xb4pital Europ\xc3\xa9en Georges Pompidou, Hypertension Unit, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bertherat</LastName>\n                    <ForeName>J\xc3\xa9r\xc3\xb4me</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>INSERM, U1016, Institut Cochin, Paris, France. 10 CNRS UMR8104, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Rare Adrenal Cancer Network COMETE, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>de Reyni\xc3\xa8s</LastName>\n                    <ForeName>Aur\xc3\xa9lien</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Programme Cartes d\'Identit\xc3\xa9 des Tumeurs, Ligue Nationale Contre Le Cancer, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Londo\xc3\xb1o-Vallejo</LastName>\n                    <ForeName>Arturo</ForeName>\n                    <Initials>A</Initials>\n                    <Identifier Source="ORCID">0000-0003-3535-7563</Identifier>\n                    <AffiliationInfo>\n                        <Affiliation>CNRS, UMR3244, Institut Curie, PSL Research University, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Sorbonne Universit\xc3\xa9s, UPMC, Univ Paris 06, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Favier</LastName>\n                    <ForeName>Judith</ForeName>\n                    <Initials>J</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>INSERM, UMR970, Paris-Cardiovascular Research Center, Equipe Labellis\xc3\xa9e par la Ligue contre le Cancer, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Universit\xc3\xa9 Paris Descartes, Sorbonne Paris Cit\xc3\xa9, Facult\xc3\xa9 de M\xc3\xa9decine, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Castro-Vega</LastName>\n                    <ForeName>Luis Jaime</ForeName>\n                    <Initials>LJ</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>INSERM, UMR970, Paris-Cardiovascular Research Center, Equipe Labellis\xc3\xa9e par la Ligue contre le Cancer, Paris, France. luis-jaime.castro-vega@inserm.fr.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Universit\xc3\xa9 Paris Descartes, Sorbonne Paris Cit\xc3\xa9, Facult\xc3\xa9 de M\xc3\xa9decine, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Gimenez-Roqueplo</LastName>\n                    <ForeName>Anne-Paule</ForeName>\n                    <Initials>AP</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>INSERM, UMR970, Paris-Cardiovascular Research Center, Equipe Labellis\xc3\xa9e par la Ligue contre le Cancer, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Universit\xc3\xa9 Paris Descartes, Sorbonne Paris Cit\xc3\xa9, Facult\xc3\xa9 de M\xc3\xa9decine, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Assistance Publique-H\xc3\xb4pitaux de Paris, H\xc3\xb4pital Europ\xc3\xa9en Georges Pompidou, Department of Genetics, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>Programme Cartes d\'Identit\xc3\xa9 des Tumeurs, Ligue Nationale Contre Le Cancer, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                    <AffiliationInfo>\n                        <Affiliation>CNRS, UMR3244, Institut Curie, PSL Research University, Paris, France.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>09</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>United States</Country>\n            <MedlineTA>Clin Cancer Res</MedlineTA>\n            <NlmUniqueID>9502500</NlmUniqueID>\n            <ISSNLinking>1078-0432</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>EC 2.7.7.49</RegistryNumber>\n                <NameOfSubstance UI="D019098">Telomerase</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 3.6.4.12</RegistryNumber>\n                <NameOfSubstance UI="C092332">ATRX protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 3.6.4.12</RegistryNumber>\n                <NameOfSubstance UI="D000075924">X-linked Nuclear Protein</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D002471" MajorTopicYN="N">Cell Transformation, Neoplastic</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019175" MajorTopicYN="N">DNA Methylation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004252" MajorTopicYN="N">DNA Mutational Analysis</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D004789" MajorTopicYN="N">Enzyme Activation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009367" MajorTopicYN="N">Neoplasm Staging</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010235" MajorTopicYN="N">Paraganglioma</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010673" MajorTopicYN="N">Pheochromocytoma</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n                <QualifierName UI="Q000401" MajorTopicYN="N">mortality</QualifierName>\n                <QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011379" MajorTopicYN="N">Prognosis</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D011401" MajorTopicYN="N">Promoter Regions, Genetic</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019098" MajorTopicYN="N">Telomerase</DescriptorName>\n                <QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000073336" MajorTopicYN="N">Whole Genome Sequencing</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000075924" MajorTopicYN="N">X-linked Nuclear Protein</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n                <QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName>\n            </MeshHeading>\n        </MeshHeadingList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2018</Year>\n                <Month>03</Month>\n                <Day>06</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2018</Year>\n                <Month>07</Month>\n                <Day>30</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>03</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>12</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>2</Month>\n                <Day>28</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2018</Year>\n                <Month>10</Month>\n                <Day>11</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">30301828</ArticleId>\n            <ArticleId IdType="pii">1078-0432.CCR-18-0139</ArticleId>\n            <ArticleId IdType="doi">10.1158/1078-0432.CCR-18-0139</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'